Anebulo Pharmaceuticals, Inc. (ANEB) KPIs and segments

ANEBNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026Score 0/30

$0.00+0.00 (+75.00%)

Close on Oct 19, 2026Market cap $28.76KP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Anebulo Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Anebulo Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?